APA   Click to copy
Shimizu, S., Kasai, S., Suzuki, C., Kon, T., Suganuma, H., Suzuki, S., … Itoh, K. (2026). Efficacy of 42-month oral administration of glucoraphanin in preventing cognitive decline in individuals at elevated risk of dementia, including those with mild cognitive impairment: a randomized, double-blind, placebo-controlled pilot study. Front Nutr, 13, 1740494. https://doi.org/10.3389/fnut.2026.1740494

Chicago/Turabian   Click to copy
Shimizu, Sunao, Shuya Kasai, Chieko Suzuki, Tomoya Kon, Hiroyuki Suganuma, Shigenori Suzuki, Koichi Murashita, et al. “Efficacy of 42-Month Oral Administration of Glucoraphanin in Preventing Cognitive Decline in Individuals at Elevated Risk of Dementia, Including Those with Mild Cognitive Impairment: a Randomized, Double-Blind, Placebo-Controlled Pilot Study.” Front Nutr 13 (2026): 1740494.

MLA   Click to copy
Shimizu, Sunao, et al. “Efficacy of 42-Month Oral Administration of Glucoraphanin in Preventing Cognitive Decline in Individuals at Elevated Risk of Dementia, Including Those with Mild Cognitive Impairment: a Randomized, Double-Blind, Placebo-Controlled Pilot Study.” Front Nutr, vol. 13, 2026, p. 1740494, doi:10.3389/fnut.2026.1740494.

@article{shimizu2026a,
  title = {Efficacy of 42-month oral administration of glucoraphanin in preventing cognitive decline in individuals at elevated risk of dementia, including those with mild  cognitive impairment: a randomized, double-blind, placebo-controlled pilot study.},
  year = {2026},
  address = {Switzerland},
  journal = {Front Nutr},
  pages = {1740494},
  volume = {13},
  doi = {10.3389/fnut.2026.1740494},
  author = {Shimizu, Sunao and Kasai, Shuya and Suzuki, Chieko and Kon, Tomoya and Suganuma, Hiroyuki and Suzuki, Shigenori and Murashita, Koichi and Nakaji, Shigeyuki and Ihara, Kazushige and Tomiyama, Masahiko and Itoh, Ken}
}